A Closer Look At The US Pricing Pushback
This article was originally published in Scrip
Critics of high prescription drug prices are making headlines in the US, and politicians on the presidential campaign trail and on Capitol Hill are talking about government-imposed price controls. But the real news may be unfolding behind the scenes in the private health insurance market, as Cathy Kelly finds out.
Register for our free email digests: